Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear Colleagues Breaking News We are so excited that Prof. Jennifer Elisseeff Johns Hopkins has accepted our invitation to be a Plenary Speaker for the upcoming 2022 CBS Conference in Banff Prof...

Why register in the CBS mentorship and professional development program? A PhD for what and then what? This is a question I asked myself during my PhD and my two postdocs...

The CBS Board of Directors Communications Committee is excited to announce that our website has an updated look...

GOLD 2022 Webinars Webinar 8 Biomedical applications of gold in vivo applications and technologies, injectable nanoparticles and pharmacology Cancer nanomedicine Overcoming the challenges in current radiotherapy using gold nanoparticles Dr...

While injectable hydrogels have several advantages in the context of experimental medicine and tissue engineering, their relatively weak mechanical properties and isotropic network structure often limit their practical applications or translation to clinical use...

The rapid emergence of drug resistant pathogens is the major dilemma of this era. In fact, World Health Organization WHO has stated a dire warning that we are entering an era of post-antibiotics and hence, there is a pressing need to find novel ways to empower the drug resistant pathogens...

Designing materials for bone tissue regeneration necessitates the provision of various properties to mimic the tissue microenvironment...

In recent years, magnesium and its alloys have received much attention as a new biomaterial in orthopedic applications due to their biodegradability, biocompatibility, and their mechanical properties that are similar to natural bone...

Hemophilia is a bleeding disorder that affects roughly 1 in 5000 live births. A form of this disease, hemophilia B, is caused by deficiencies of the clotting protein, factor IX FIX , which is part of the coagulation cascade that, when activated by vascular injury, generates fibrin and its crosslinker, factor XIIIa FXIIIa ...